Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Iovance Biotherapeutics stock (IOVA)

Buy Iovance Biotherapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Iovance Biotherapeutics is a biotechnology business based in the US. Iovance Biotherapeutics shares (IOVA) are listed on the NASDAQ and all prices are listed in US Dollars. Iovance Biotherapeutics employs 557 staff and has a trailing 12-month revenue of around $1.9 million.

Our top picks for where to buy Iovance Biotherapeutics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Iovance Biotherapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – IOVA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Iovance Biotherapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Iovance Biotherapeutics stock price (NASDAQ: IOVA)

Use our graph to track the performance of IOVA stocks over time.

Iovance Biotherapeutics shares at a glance

Information last updated 2024-07-07.
Latest market close$7.54
52-week range$3.21 - $18.33
50-day moving average $9.80
200-day moving average $8.94
Wall St. target price$25.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.81

Is it a good time to buy Iovance Biotherapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Iovance Biotherapeutics price performance over time

Historical closes compared with the close of $7.54 from 2024-07-09

1 week (2024-07-03) 2.03%
1 month (2024-06-11) -12.53%
3 months (2024-04-11) -42.84%
6 months (2024-01-11) -17.60%
1 year (2023-07-11) -4.92%
2 years (2022-07-07) N/A
3 years (2021-07-09) 26.63
5 years (2019-07-11) 23.93

Iovance Biotherapeutics financials

Revenue TTM $1.9 million
Gross profit TTM $0
Return on assets TTM -34.48%
Return on equity TTM -66.77%
Profit margin 0%
Book value $2.43
Market Capitalization $2 billion

TTM: trailing 12 months

Iovance Biotherapeutics share dividends

We're not expecting Iovance Biotherapeutics to pay a dividend over the next 12 months.

Have Iovance Biotherapeutics's shares ever split?

Iovance Biotherapeutics's shares were split on a 1:100 basis on 25 September 2013. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Iovance Biotherapeutics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Iovance Biotherapeutics shares which in turn could have impacted Iovance Biotherapeutics's share price.

Iovance Biotherapeutics share price volatility

Over the last 12 months, Iovance Biotherapeutics's shares have ranged in value from as little as $3.21 up to $18.33. A popular way to gauge a stock's volatility is its "beta".

IOVA.US volatility(beta: 0.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iovance Biotherapeutics's is 0.628. This would suggest that Iovance Biotherapeutics's shares are less volatile than average (for this exchange).

Iovance Biotherapeutics overview

Iovance Biotherapeutics, Inc. , a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc. ; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.

Frequently asked questions

What percentage of Iovance Biotherapeutics is owned by insiders or institutions?
Currently 0.538% of Iovance Biotherapeutics shares are held by insiders and 89.056% by institutions.
How many people work for Iovance Biotherapeutics?
Latest data suggests 557 work at Iovance Biotherapeutics.
When does the fiscal year end for Iovance Biotherapeutics?
Iovance Biotherapeutics's fiscal year ends in December.
Where is Iovance Biotherapeutics based?
Iovance Biotherapeutics's address is: 825 Industrial Road, San Carlos, CA, United States, 94070
What is Iovance Biotherapeutics's ISIN number?
Iovance Biotherapeutics's international securities identification number is: US4622601007
What is Iovance Biotherapeutics's CUSIP number?
Iovance Biotherapeutics's Committee on Uniform Securities Identification Procedures number is: 37182R102

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site